{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T17:45:22Z","timestamp":1793727922739,"version":"4.6.1"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T00:00:00Z","timestamp":1763510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T00:00:00Z","timestamp":1763510400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100004569","name":"Ministerstwo Edukacji i Nauki","doi-asserted-by":"publisher","award":["Excellence Initiative - Research University"],"award-info":[{"award-number":["Excellence Initiative - Research University"]}],"id":[{"id":"10.13039\/501100004569","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004569","name":"Ministerstwo Edukacji i Nauki","doi-asserted-by":"publisher","award":["Excellence Initiative - Research University"],"award-info":[{"award-number":["Excellence Initiative - Research University"]}],"id":[{"id":"10.13039\/501100004569","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-24648-7","type":"journal-article","created":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T12:29:00Z","timestamp":1763555340000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Associations between asprosin, insulin resistance, and oxidative stress in adults with obesity"],"prefix":"10.1038","volume":"15","author":[{"given":"Maria","family":"Ko\u015bciuszko","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelika","family":"Buczy\u0144ska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ewa","family":"Duraj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnieszka","family":"Adamska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katarzyna","family":"Siewko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam Jacek","family":"Kr\u0119towski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Pop\u0142awska-Kita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,19]]},"reference":[{"issue":"10456","key":"24648_CR1","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1016\/S0140-6736(24)01210-8","volume":"404","author":"I Lingvay","year":"2024","unstructured":"Lingvay, I., Cohen, R. V., Roux, C. W. L. & Sumithran, P. Obesity in adults. Lancet (London Engl. 404 (10456), 10456:972\u2013987. https:\/\/doi.org\/10.1016\/S0140-6736(24)01210-8 (2024).","journal-title":"Lancet (London Engl."},{"issue":"6","key":"24648_CR2","doi-asserted-by":"publisher","first-page":"e13440","DOI":"10.1111\/obr.13440","volume":"23","author":"M Sumi\u0144ska","year":"2022","unstructured":"Sumi\u0144ska, M. et al. Historical and cultural aspects of obesity: from a symbol of wealth and prosperity to the epidemic of the 21st century. Obes. Reviews: Official J. Int. Association Study Obes. 23 (6), e13440. https:\/\/doi.org\/10.1111\/obr.13440 (2022).","journal-title":"Obes. Reviews: Official J. Int. Association Study Obes."},{"issue":"3","key":"24648_CR3","doi-asserted-by":"publisher","first-page":"300060523116454","DOI":"10.1177\/03000605231164548","volume":"51","author":"CE Kosmas","year":"2023","unstructured":"Kosmas, C. E. et al. Insulin resistance and cardiovascular disease. J. Int. Med. Res. 51 (3), 3000605231164548. https:\/\/doi.org\/10.1177\/03000605231164548 (2023).","journal-title":"J. Int. Med. Res."},{"issue":"4","key":"24648_CR4","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1016\/j.cmet.2024.03.002","volume":"36","author":"MC Petersen","year":"2024","unstructured":"Petersen, M. C. et al. Cardiometabolic characteristics of people with metabolically healthy and unhealthy obesity. Cell Metabol. 36 (4), 745\u2013761e5. https:\/\/doi.org\/10.1016\/j.cmet.2024.03.002 (2024).","journal-title":"Cell Metabol."},{"issue":"2","key":"24648_CR5","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1007\/s12020-022-03087-8","volume":"77","author":"L Vigna","year":"2022","unstructured":"Vigna, L. et al. Insulin resistance and cardiometabolic indexes: comparison of concordance in working-age subjects with overweight and obesity. Endocrine 77 (2), 231\u2013241. https:\/\/doi.org\/10.1007\/s12020-022-03087-8 (2022).","journal-title":"Endocrine"},{"issue":"8","key":"24648_CR6","doi-asserted-by":"publisher","first-page":"102581","DOI":"10.1016\/j.dsx.2022.102581","volume":"16","author":"DL Tahapary","year":"2022","unstructured":"Tahapary, D. L. et al. Challenges in the diagnosis of insulin resistance: focusing on the role of HOMA-IR and Tryglyceride\/glucose index. Diabetes Metab. Syndr. 16 (8), 102581. https:\/\/doi.org\/10.1016\/j.dsx.2022.102581 (2022).","journal-title":"Diabetes Metab. Syndr."},{"key":"24648_CR7","doi-asserted-by":"publisher","first-page":"18495","DOI":"10.1038\/srep18495","volume":"5","author":"M Zhang","year":"2015","unstructured":"Zhang, M., Hu, T., Zhang, S. & Zhou, L. Associations of different adipose tissue depots with insulin resistance: A systematic review and Meta-analysis of observational studies. Sci. Rep. 5, 18495. https:\/\/doi.org\/10.1038\/srep18495 (2015).","journal-title":"Sci. Rep."},{"key":"24648_CR8","doi-asserted-by":"publisher","first-page":"64","DOI":"10.3389\/fendo.2020.00064","volume":"11","author":"M Yuan","year":"2020","unstructured":"Yuan, M. et al. A novel player in metabolic diseases. Front. Endocrinol. (Lausanne). 11, 64. https:\/\/doi.org\/10.3389\/fendo.2020.00064 (2020). Published 2020 Feb 19.","journal-title":"Front. Endocrinol. (Lausanne)"},{"issue":"2","key":"24648_CR9","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1007\/s12079-020-00566-3","volume":"14","author":"ML Muthu","year":"2020","unstructured":"Muthu, M. L. & Reinhardt, D. P. Fibrillin-1 and fibrillin-1-derived Asprosin in adipose tissue function and metabolic disorders. J. Cell. Commun. Signal. 14 (2), 159\u2013173. https:\/\/doi.org\/10.1007\/s12079-020-00566-3 (2020).","journal-title":"J. Cell. Commun. Signal."},{"issue":"1","key":"24648_CR10","doi-asserted-by":"publisher","first-page":"e33653","DOI":"10.7759\/cureus.33653","volume":"15","author":"KS Jog","year":"2023","unstructured":"Jog, K. S., Eagappan, S., Santharam, R. K. & Subbiah, S. Comparison of novel biomarkers of insulin resistance with homeostasis model assessment of insulin resistance, its correlation to metabolic syndrome in South Indian population and proposition of population specific cutoffs for these indices. Cureus 15 (1), e33653. https:\/\/doi.org\/10.7759\/cureus.33653 (2023).","journal-title":"Cureus"},{"issue":"16","key":"24648_CR11","doi-asserted-by":"publisher","first-page":"2783","DOI":"10.1080\/10408398.2020.1788501","volume":"61","author":"ADM Brito","year":"2021","unstructured":"Brito, A. D. M. et al. Predictive capacity of triglyceride-glucose (TyG) index for insulin resistance and cardiometabolic risk in children and adolescents: a systematic review. Crit. Rev. Food Sci. Nutr. 61 (16), 2783\u20132792. https:\/\/doi.org\/10.1080\/10408398.2020.1788501 (2021).","journal-title":"Crit. Rev. Food Sci. Nutr."},{"issue":"3","key":"24648_CR12","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1016\/j.numecd.2021.11.017","volume":"32","author":"DH Son","year":"2022","unstructured":"Son, D. H., Lee, H. S., Lee, Y. J., Lee, J. H. & Han, J. H. Comparison of triglyceride-glucose index and HOMA-IR for predicting prevalence and incidence of metabolic syndrome. Nutr. Metab. Cardiovasc. Dis. 32 (3), 596\u2013604. https:\/\/doi.org\/10.1016\/j.numecd.2021.11.017 (2022).","journal-title":"Nutr. Metab. Cardiovasc. Dis."},{"key":"24648_CR13","doi-asserted-by":"publisher","unstructured":"S\u00e1nchez-Garc\u00eda, A. et al. Diagnostic accuracy of the triglyceride and glucose index for insulin resistance: A systematic review. Int. J. Endocrinol. 2020 (4678526). https:\/\/doi.org\/10.1155\/2020\/4678526 (2020).","DOI":"10.1155\/2020\/4678526"},{"issue":"6","key":"24648_CR14","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1111\/pedi.12303","volume":"17","author":"NS Mohd Nor","year":"2016","unstructured":"Mohd Nor, N. S., Lee, S., Bacha, F., Tfayli, H. & Arslanian, S. Triglyceride glucose index as a surrogate measure of insulin sensitivity in obese adolescents with normoglycemia, prediabetes, and type 2 diabetes mellitus: comparison with the hyperinsulinemic-euglycemic clamp. Pediatr. Diabetes. 17 (6), 458\u2013465. https:\/\/doi.org\/10.1111\/pedi.12303 (2016).","journal-title":"Pediatr. Diabetes"},{"issue":"9","key":"24648_CR15","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.2337\/diacare.22.9.1462","volume":"22","author":"M Matsuda","year":"1999","unstructured":"Matsuda, M. & DeFronzo, R. A. Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care. 22 (9), 1462\u20131470. https:\/\/doi.org\/10.2337\/diacare.22.9.1462 (1999).","journal-title":"Diabetes Care"},{"key":"24648_CR16","doi-asserted-by":"publisher","DOI":"10.1515\/hmbci-2023-0061","author":"K Rani","year":"2024","unstructured":"Rani, K., Patil, P., Bharti, P., Kumar, S. & Prabhala The undervalued league of insulin resistance testing: Uncovering their importance. Horm. Mol. Biol. Clin. Investig. https:\/\/doi.org\/10.1515\/hmbci-2023-0061 (2024).","journal-title":"Horm. Mol. Biol. Clin. Investig"},{"issue":"3","key":"24648_CR17","doi-asserted-by":"publisher","first-page":"187","DOI":"10.5507\/bp.2019.021","volume":"163","author":"S Placzkowska","year":"2019","unstructured":"Placzkowska, S., Pawlik-Sobecka, L., Kokot, I. & Piwowar, A. Indirect insulin resistance detection: current clinical trends and laboratory limitations. Biomed. Pap Med. Fac. Univ. Palacky Olomouc Czech Repub. 163 (3), 187\u2013199. https:\/\/doi.org\/10.5507\/bp.2019.021 (2019).","journal-title":"Biomed. Pap Med. Fac. Univ. Palacky Olomouc Czech Repub."},{"issue":"7","key":"24648_CR18","doi-asserted-by":"publisher","first-page":"2402","DOI":"10.1210\/jcem.85.7.6661","volume":"85","author":"A Katz","year":"2000","unstructured":"Katz, A. et al. Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. J. Clin. Endocrinol. Metab. 85 (7), 2402\u20132410. https:\/\/doi.org\/10.1210\/jcem.85.7.6661 (2000).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"24648_CR19","doi-asserted-by":"publisher","unstructured":"Tang, X., Zhang, K. & He, R. The association of triglyceride-glucose and triglyceride-glucose related indices with the risk of heart disease in a national. Cardiovasc Diabetol. ;24(1):54. (2025). https:\/\/doi.org\/10.1186\/s12933-025-02621-y. Erratum in: Cardiovasc Diabetol. 2025;24(1):174. doi: 10.1186\/s12933-025-02726-4.","DOI":"10.1186\/s12933-025-02621-y"},{"issue":"4","key":"24648_CR20","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1159\/000503808","volume":"75","author":"M Wang","year":"2019","unstructured":"Wang, M. et al. Serum Asprosin concentrations are increased and associated with insulin resistance in children with obesity. Ann. Nutr. Metab. 75 (4), 205\u2013212. https:\/\/doi.org\/10.1159\/000503808 (2019).","journal-title":"Ann. Nutr. Metab."},{"issue":"3","key":"24648_CR21","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1016\/j.cell.2016.02.063","volume":"165","author":"C Romere","year":"2016","unstructured":"Romere, C. et al. Asprosin, a Fasting-Induced glucogenic protein hormone. Cell 165 (3), 566\u2013579. https:\/\/doi.org\/10.1016\/j.cell.2016.02.063 (2016).","journal-title":"Cell"},{"issue":"Spec Issue","key":"24648_CR22","first-page":"179","volume":"11","author":"M Jahangiri","year":"2021","unstructured":"Jahangiri, M., Shahrbanian, S. & Hackney, A. C. Changes in the level of Asprosin as a novel adipocytokine after different types of resistance training. J. Chem. Health Risks. 11 (Spec Issue), 179\u2013188 (2021).","journal-title":"J. Chem. Health Risks"},{"issue":"6","key":"24648_CR23","doi-asserted-by":"publisher","first-page":"2124","DOI":"10.26355\/eurrev_202203_28360","volume":"26","author":"K Ugur","year":"2022","unstructured":"Ugur, K. et al. Asprosin, visfatin and subfatin as new biomarkers of obesity and metabolic syndrome. Eur. Rev. Med. Pharmacol. Sci. 26 (6), 2124\u20132133. https:\/\/doi.org\/10.26355\/eurrev_202203_28360 (2022).","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"24648_CR24","doi-asserted-by":"publisher","first-page":"1452277","DOI":"10.3389\/fendo.2024.1452277","volume":"15","author":"SH Kim","year":"2024","unstructured":"Kim, S. H., Kim, S. E. & Chun, Y. H. The association of plasma Asprosin with anthropometric and metabolic parameters in Korean children and adolescents. Front. Endocrinol. (Lausanne). 15, 1452277. https:\/\/doi.org\/10.3389\/fendo.2024.1452277 (2024).","journal-title":"Front. Endocrinol. (Lausanne)"},{"issue":"9","key":"24648_CR25","doi-asserted-by":"publisher","first-page":"7898","DOI":"10.3390\/ijms24097898","volume":"24","author":"SK Masenga","year":"2023","unstructured":"Masenga, S. K., Kabwe, L. S., Chakulya, M. & Kirabo, A. Mechanisms of oxidative stress in metabolic syndrome. Int. J. Mol. Sci. 24 (9), 7898. https:\/\/doi.org\/10.3390\/ijms24097898 (2023).","journal-title":"Int. J. Mol. Sci."},{"issue":"1885","key":"24648_CR26","doi-asserted-by":"publisher","first-page":"20220210","DOI":"10.1098\/rstb.2022.0210","volume":"378","author":"BE Corkey","year":"2023","unstructured":"Corkey, B. E. Reactive oxygen species: role in obesity and mitochondrial energy efficiency. Philos. Trans. R Soc. Lond. B Biol. Sci. 378 (1885), 20220210. https:\/\/doi.org\/10.1098\/rstb.2022.0210 (2023).","journal-title":"Philos. Trans. R Soc. Lond. B Biol. Sci."},{"issue":"9","key":"24648_CR27","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.3390\/biom14091123","volume":"14","author":"A Senyigit","year":"2024","unstructured":"Senyigit, A., Durmus, S., Gelisgen, R. & Uzun, H. Oxidative stress and Asprosin levels in type 2 diabetic patients with good and poor glycemic control. Biomolecules 14 (9), 1123. https:\/\/doi.org\/10.3390\/biom14091123 (2024).","journal-title":"Biomolecules"},{"key":"24648_CR28","doi-asserted-by":"publisher","first-page":"155477","DOI":"10.1016\/j.cyto.2021.155477","volume":"142","author":"D Corica","year":"2021","unstructured":"Corica, D. et al. Asprosin serum levels and glucose homeostasis in children with obesity. Cytokine 142, 155477. https:\/\/doi.org\/10.1016\/j.cyto.2021.155477 (2021).","journal-title":"Cytokine"},{"issue":"1","key":"24648_CR29","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s12902-024-01565-w","volume":"24","author":"Y Zhang","year":"2024","unstructured":"Zhang, Y., Zhang, Y., Yang, B., Li, S. & Jia, R. Circulating levels of Asprosin in children with obesity: a systematic review and meta-analysis. BMC Endocr. Disord. 24 (1), 36. https:\/\/doi.org\/10.1186\/s12902-024-01565-w (2024).","journal-title":"BMC Endocr. Disord"},{"issue":"1","key":"24648_CR30","doi-asserted-by":"publisher","first-page":"55","DOI":"10.5603\/EP.a2022.0093","volume":"74","author":"G Hu","year":"2023","unstructured":"Hu, G., Si, W., Zhang, Q. & Lv, F. Circulating asprosin, irisin, and abdominal obesity in Chinese patients with type 2 diabetes mellitus: a case-control study. Endokrynol Pol. 74 (1), 55\u201362. https:\/\/doi.org\/10.5603\/EP.a2022.0093 (2023).","journal-title":"Endokrynol Pol."},{"issue":"1","key":"24648_CR31","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1038\/s41598-024-51473-1","volume":"14","author":"A Suder","year":"2024","unstructured":"Suder, A. et al. Exercise-induced effects on Asprosin and indices of atherogenicity and insulin resistance in males with metabolic syndrome: a randomized controlled trial. Sci. Rep. 14 (1), 985. https:\/\/doi.org\/10.1038\/s41598-024-51473-1 (2024).","journal-title":"Sci. Rep."},{"issue":"8","key":"24648_CR32","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1002\/oby.23471","volume":"30","author":"H Cantay","year":"2022","unstructured":"Cantay, H., Binnetoglu, K., Gul, H. F. & Bingol, S. A. Investigation of serum and adipose tissue levels of Asprosin in patients with severe obesity undergoing sleeve gastrectomy. Obes. (Silver Spring). 30 (8), 1639\u20131646. https:\/\/doi.org\/10.1002\/oby.23471 (2022).","journal-title":"Obes. (Silver Spring)"},{"issue":"2","key":"24648_CR33","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1515\/jcim-2020-0073","volume":"18","author":"M Zaki","year":"2020","unstructured":"Zaki, M., Amin, D. & Mohamed, R. Body composition, phenotype and central obesity indices in Egyptian women with non-alcoholic fatty liver disease. J. Complement. Integr. Med. 18 (2), 385\u2013390. https:\/\/doi.org\/10.1515\/jcim-2020-0073 (2020).","journal-title":"J. Complement. Integr. Med."},{"issue":"19","key":"24648_CR34","doi-asserted-by":"publisher","first-page":"12449","DOI":"10.3390\/ijerph191912449","volume":"19","author":"M Ga\u017earov\u00e1","year":"2022","unstructured":"Ga\u017earov\u00e1, M., Bihari, M., Lorkov\u00e1, M., Len\u00e1rtov\u00e1, P. & Hab\u00e1nov\u00e1, M. The use of different anthropometric indices to assess the body composition of young women in relation to the incidence of Obesity, sarcopenia and the premature mortality risk. Int. J. Environ. Res. Public. Health. 19 (19), 12449. https:\/\/doi.org\/10.3390\/ijerph191912449 (2022).","journal-title":"Int. J. Environ. Res. Public. Health"},{"issue":"3","key":"24648_CR35","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1159\/000499607","volume":"12","author":"B Jensen","year":"2019","unstructured":"Jensen, B. et al. Limitations of Fat-Free mass for the assessment of muscle mass in obesity. Obes. Facts. 12 (3), 307\u2013315. https:\/\/doi.org\/10.1159\/000499607 (2019).","journal-title":"Obes. Facts"},{"issue":"1 Suppl","key":"24648_CR36","doi-asserted-by":"publisher","first-page":"14","DOI":"10.26355\/eurrev_202112_27329","volume":"25","author":"G Camilleri","year":"2021","unstructured":"Camilleri, G. et al. Genetics of fat deposition. Eur. Rev. Med. Pharmacol. Sci. 25 (1 Suppl), 14\u201322. https:\/\/doi.org\/10.26355\/eurrev_202112_27329 (2021).","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"issue":"6","key":"24648_CR37","doi-asserted-by":"publisher","first-page":"1568","DOI":"10.3390\/biomedicines11061568","volume":"11","author":"M Mirr","year":"2023","unstructured":"Mirr, M. et al. Serum Asprosin correlates with indirect insulin resistance indices. Biomedicines 11 (6), 1568. https:\/\/doi.org\/10.3390\/biomedicines11061568 (2023). Published 2023 May 28.","journal-title":"Biomedicines"},{"key":"24648_CR38","doi-asserted-by":"publisher","first-page":"7375294","DOI":"10.1155\/2018\/7375294","volume":"2018","author":"X Li","year":"2018","unstructured":"Li, X. et al. Plasma Asprosin levels are associated with glucose Metabolism, Lipid, and sex hormone profiles in females with Metabolic-Related diseases. Mediators Inflamm. 2018, 7375294. https:\/\/doi.org\/10.1155\/2018\/7375294 (2018).","journal-title":"Mediators Inflamm."},{"issue":"5","key":"24648_CR39","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1172\/JCI114857","volume":"86","author":"F Zurlo","year":"1990","unstructured":"Zurlo, F., Larson, K., Bogardus, C. & Ravussin, E. Skeletal muscle metabolism is a major determinant of resting energy expenditure. J. Clin. Invest. 86 (5), 1423\u20131427. https:\/\/doi.org\/10.1172\/JCI114857 (1990).","journal-title":"J. Clin. Invest."},{"issue":"19","key":"24648_CR40","doi-asserted-by":"publisher","first-page":"5862","DOI":"10.3390\/jcm13195862","volume":"13","author":"E Gitsi","year":"2024","unstructured":"Gitsi, E., Kokkinos, A., Konstantinidou, S. K., Livadas, S. & Argyrakopoulou, G. The relationship between resting metabolic rate and body composition in people living with overweight and obesity. J. Clin. Med. 13 (19), 5862. https:\/\/doi.org\/10.3390\/jcm13195862 (2024).","journal-title":"J. Clin. Med."},{"issue":"7\u20139","key":"24648_CR41","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1089\/ars.2023.0383","volume":"41","author":"F Zheng","year":"2024","unstructured":"Zheng, F. et al. Intervention of Asprosin attenuates oxidative stress and Neointima formation in vascular injury. Antioxid. Redox Signal. 41 (7\u20139), 488\u2013504. https:\/\/doi.org\/10.1089\/ars.2023.0383 (2024).","journal-title":"Antioxid. Redox Signal."},{"issue":"1","key":"24648_CR42","doi-asserted-by":"publisher","first-page":"2152790","DOI":"10.1080\/09513590.2022.2152790","volume":"39","author":"FR P\u00e9rez-L\u00f3pez","year":"2023","unstructured":"P\u00e9rez-L\u00f3pez, F. R. et al. Asprosin levels in women with and without the polycystic ovary syndrome: a systematic review and meta-analysis. Gynecol. Endocrinol. 39 (1), 2152790. https:\/\/doi.org\/10.1080\/09513590.2022.2152790 (2023).","journal-title":"Gynecol. Endocrinol."},{"issue":"7","key":"24648_CR43","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1038\/s41366-024-01495-6","volume":"48","author":"S Chen","year":"2024","unstructured":"Chen, S. et al. Asprosin contributes to pathogenesis of obesity by adipocyte mitophagy induction to inhibit white adipose Browning in mice. Int. J. Obes. (Lond). 48 (7), 913\u2013922. https:\/\/doi.org\/10.1038\/s41366-024-01495-6 (2024).","journal-title":"Int. J. Obes. (Lond)"},{"issue":"4","key":"24648_CR44","doi-asserted-by":"publisher","first-page":"e0265645","DOI":"10.1371\/journal.pone.0265645","volume":"17","author":"R Huang","year":"2022","unstructured":"Huang, R. et al. A cross-sectional comparative study on the effects of body mass index and exercise\/sedentary on serum Asprosin in male college students. PLoS One. 17 (4), e0265645. https:\/\/doi.org\/10.1371\/journal.pone.0265645 (2022).","journal-title":"PLoS One"},{"key":"24648_CR45","doi-asserted-by":"publisher","first-page":"726783","DOI":"10.3389\/fphys.2021.726783","volume":"12","author":"M Kantorowicz","year":"2021","unstructured":"Kantorowicz, M. et al. Nordic walking at maximal fat oxidation intensity decreases Circulating Asprosin and visceral obesity in women with metabolic disorders. Front. Physiol. 12, 726783. https:\/\/doi.org\/10.3389\/fphys.2021.726783 (2021).","journal-title":"Front. Physiol."},{"issue":"1","key":"24648_CR46","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s12902-024-01560-1","volume":"24","author":"J Cui","year":"2024","unstructured":"Cui, J. et al. Association of serum Asprosin with metabolic dysfunction-associated fatty liver disease in older adult type 2 diabetic patients: a cross-sectional study. BMC Endocr. Disord. 24 (1), 27. https:\/\/doi.org\/10.1186\/s12902-024-01560-1 (2024). Published 2024 Mar 4.","journal-title":"BMC Endocr. Disord"},{"issue":"5\u20136","key":"24648_CR47","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1024\/0300-9831\/a000675","volume":"92","author":"MA Farhangi","year":"2022","unstructured":"Farhangi, M. A., Vajdi, M. & Fathollahi, P. Dietary total antioxidant capacity (TAC), general and central obesity indices and serum lipids among adults: an updated systematic review and meta-analysis. Int. J. Vitam. Nutr. Res. 92 (5\u20136), 406\u2013422. https:\/\/doi.org\/10.1024\/0300-9831\/a000675 (2022).","journal-title":"Int. J. Vitam. Nutr. Res."},{"issue":"13","key":"24648_CR48","doi-asserted-by":"publisher","first-page":"10978","DOI":"10.3390\/ijms241310978","volume":"24","author":"A Silvestrini","year":"2023","unstructured":"Silvestrini, A., Meucci, E., Ricerca, B. M. & Mancini, A. Total antioxidant capacity: biochemical aspects and clinical significance. Int. J. Mol. Sci. 24 (13), 10978. https:\/\/doi.org\/10.3390\/ijms241310978 (2023).","journal-title":"Int. J. Mol. Sci."},{"key":"24648_CR49","doi-asserted-by":"publisher","unstructured":"Hong, T. et al. High serum Asprosin levels are associated with presence of metabolic syndrome. Int. J. Endocrinol. 2021 (6622129). https:\/\/doi.org\/10.1155\/2021\/6622129 (2021).","DOI":"10.1155\/2021\/6622129"},{"key":"24648_CR50","doi-asserted-by":"publisher","unstructured":"Wang, Y. et al. Plasma Asprosin Concentrations Are Increased in Individuals with Glucose Dysregulation and Correlated with Insulin Resistance and First-Phase Insulin Secretion. Mediators Inflamm. :9471583. (2018). https:\/\/doi.org\/10.1155\/2018\/9471583 (2018).","DOI":"10.1155\/2018\/9471583"},{"key":"24648_CR51","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.clinbiochem.2022.04.01","volume":"109\u2013110","author":"X Deng","year":"2022","unstructured":"Deng, X. et al. Association between Circulating Asprosin levels and carotid atherosclerotic plaque in patients with type 2 diabetes. Clin. Biochem. 109\u2013110, 44\u201350. https:\/\/doi.org\/10.1016\/j.clinbiochem.2022.04.01 (2022).","journal-title":"Clin. Biochem."},{"issue":"23","key":"24648_CR52","doi-asserted-by":"publisher","first-page":"2458","DOI":"10.3390\/healthcare12232458","volume":"12","author":"B Kim","year":"2024","unstructured":"Kim, B., Kim, G. M., Huh, U., Lee, J. & Kim, E. Association of HOMA-IR versus TyG index with diabetes in individuals without underweight or obesity. Healthc. (Basel). 12 (23), 2458. https:\/\/doi.org\/10.3390\/healthcare12232458 (2024).","journal-title":"Healthc. (Basel)"},{"issue":"6","key":"24648_CR53","doi-asserted-by":"publisher","first-page":"2579","DOI":"10.1016\/j.asjsur.2024.03.004","volume":"47","author":"D Ozturk","year":"2024","unstructured":"Ozturk, D., Sivaslioglu, A., Bulus, H. & Ozturk, B. TyG index is positively associated with HOMA-IR in cholelithiasis patients with insulin resistance: based on a retrospective observational study. Asian J. Surg. 47 (6), 2579\u20132583. https:\/\/doi.org\/10.1016\/j.asjsur.2024.03.004 (2024).","journal-title":"Asian J. Surg."},{"issue":"2","key":"24648_CR54","doi-asserted-by":"publisher","first-page":"73","DOI":"10.5603\/DK.a2022.0006","volume":"11","author":"KH Rohoma","year":"2022","unstructured":"Rohoma, K. H., Abdellrahim, A. A., Abo Elwafa, R. A. & Moawad, M. G. Study of the relationship between serum asprosin, endothelial dysfunction and insulin resistance. Clin. Diabetol. 11 (2), 73\u201379. https:\/\/doi.org\/10.5603\/DK.a2022.0006 (2022).","journal-title":"Clin. Diabetol."},{"issue":"5","key":"24648_CR55","doi-asserted-by":"publisher","first-page":"986","DOI":"10.47391\/JPMA.22-63","volume":"72","author":"VK Ramdas Nayak","year":"2022","unstructured":"Ramdas Nayak, V. K., Satheesh, P., Shenoy, M. T. & Kalra, S. Triglyceride glucose (TyG) index: A surrogate biomarker of insulin resistance. J. Pak Med. Assoc. 72 (5), 986\u2013988. https:\/\/doi.org\/10.47391\/JPMA.22-63 (2022).","journal-title":"J. Pak Med. Assoc."},{"key":"24648_CR56","doi-asserted-by":"publisher","first-page":"951689","DOI":"10.3389\/fendo.2022.951689","volume":"13","author":"Y Xue","year":"2022","unstructured":"Xue, Y., Xu, J., Li, M. & Gao, Y. Potential screening indicators for early diagnosis of NAFLD\/MAFLD and liver fibrosis: triglyceride glucose index-related parameters. Front. Endocrinol. (Lausanne). 13, 951689. https:\/\/doi.org\/10.3389\/fendo.2022.951689 (2022).","journal-title":"Front. Endocrinol. (Lausanne)"},{"issue":"23","key":"24648_CR57","doi-asserted-by":"publisher","first-page":"4969","DOI":"10.3390\/nu14234969","volume":"14","author":"J Wang","year":"2022","unstructured":"Wang, J. et al. The diagnostic and prognostic value of the Triglyceride-Glucose index in metabolic Dysfunction-Associated fatty liver disease (MAFLD): A systematic review and Meta-Analysis. Nutrients 14 (23), 4969. https:\/\/doi.org\/10.3390\/nu14234969 (2022).","journal-title":"Nutrients"},{"issue":"1","key":"24648_CR58","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/s12902-023-01311-8","volume":"23","author":"M Zhong","year":"2023","unstructured":"Zhong, M. et al. Correlation of Asprosin and Nrg-4 with type 2 diabetes mellitus complicated with coronary heart disease and the diagnostic value. BMC Endocr. Disord. 23 (1), 61. https:\/\/doi.org\/10.1186\/s12902-023-01311-8 (2023).","journal-title":"BMC Endocr. Disord"},{"key":"24648_CR59","doi-asserted-by":"publisher","DOI":"10.23812\/19-244-E","author":"P Bhadel","year":"2020","unstructured":"Bhadel, P., Shrestha, S., Sapkota, B., Li, J. Y. & Tao, H. Asprosin and type 2 diabetes mellitus: a novel potential therapeutic implication. J. Biol. Regul. Homeost. Agents. https:\/\/doi.org\/10.23812\/19-244-E (2020).","journal-title":"J. Biol. Regul. Homeost. Agents"},{"key":"24648_CR60","doi-asserted-by":"publisher","first-page":"110642","DOI":"10.1016\/j.diabres.2023.110642","volume":"199","author":"GN Ertuna","year":"2023","unstructured":"Ertuna, G. N., Sahiner, E. S., Yilmaz, F. M. & Ates, I. The role of Irisin and Asprosin level in the pathophysiology of prediabetes. Diabetes Res. Clin. Pract. 199, 110642. https:\/\/doi.org\/10.1016\/j.diabres.2023.110642 (2023).","journal-title":"Diabetes Res. Clin. Pract."},{"key":"24648_CR61","doi-asserted-by":"publisher","unstructured":"Mishra, I. et al. Asprosin-neutralizing antibodies as a treatment for metabolic syndrome. Elife. ;10:e63784. (2021). https:\/\/doi.org\/10.7554\/eLife.63784 (2021).","DOI":"10.7554\/eLife.63784"},{"issue":"10","key":"24648_CR62","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1016\/j.soard.2024.04.015","volume":"20","author":"B de Paix\u00e3o","year":"2024","unstructured":"de Paix\u00e3o, B., Figueiredo, N. & Lopes, S. The impact of the obesity onset on the inflammatory and glycemic profile of women with severe obesity. Surg. Obes. Relat. Dis. 20 (10), 976\u2013983. https:\/\/doi.org\/10.1016\/j.soard.2024.04.015 (2024).","journal-title":"Surg. Obes. Relat. Dis."},{"issue":"2","key":"24648_CR63","doi-asserted-by":"publisher","first-page":"620","DOI":"10.3390\/nu13020620","volume":"13","author":"AI Mazur-Bialy","year":"2021","unstructured":"Mazur-Bialy, A. I., Asprosin, A. & Fasting-Induced Glucogenic, and orexigenic adipokine as a new promising Player. Will it be a new factor in the treatment of Obesity, Diabetes, or infertility? A review of the literature. Nutrients 13 (2), 620. https:\/\/doi.org\/10.3390\/nu13020620 (2021). Published 2021 Feb 14.","journal-title":"Nutrients"},{"issue":"3","key":"24648_CR64","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1159\/000520333","volume":"13","author":"MA Ovali","year":"2022","unstructured":"Ovali, M. A. & Bozgeyik, I. Asprosin, a C-Terminal cleavage product of fibrillin 1 encoded by the FBN1 Gene, in health and disease. Mol. Syndromol. 13 (3), 175\u2013183. https:\/\/doi.org\/10.1159\/000520333 (2022).","journal-title":"Mol. Syndromol"},{"key":"24648_CR65","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.mce.2019.03.001","volume":"486","author":"T Lee","year":"2019","unstructured":"Lee, T., Yun, S., Jeong, J. H. & Jung, T. W. Asprosin impairs insulin secretion in response to glucose and viability through TLR4\/JNK-mediated inflammation. Mol. Cell. Endocrinol. 486, 96\u2013104. https:\/\/doi.org\/10.1016\/j.mce.2019.03.001 (2019).","journal-title":"Mol. Cell. Endocrinol."},{"issue":"1","key":"24648_CR66","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1186\/s12967-019-2096-8","volume":"17","author":"H Al-Sulaiti","year":"2019","unstructured":"Al-Sulaiti, H. et al. Metabolic signature of obesity-associated insulin resistance and type 2 diabetes. J. Transl Med. 17 (1), 348. https:\/\/doi.org\/10.1186\/s12967-019-2096-8 (2019).","journal-title":"J. Transl Med."},{"key":"24648_CR67","doi-asserted-by":"publisher","first-page":"155184","DOI":"10.1016\/j.cyto.2020.155184","volume":"134","author":"F Ke","year":"2020","unstructured":"Ke, F. et al. Combination of Asprosin and adiponectin as a novel marker for diagnosing non-alcoholic fatty liver disease. Cytokine 134, 155184. https:\/\/doi.org\/10.1016\/j.cyto.2020.155184 (2020).","journal-title":"Cytokine"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-24648-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-24648-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-24648-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T12:29:02Z","timestamp":1763555342000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-24648-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,19]]},"references-count":67,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["24648"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-24648-7","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-6939320\/v1","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,19]]},"assertion":[{"value":"20 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The procedures were approved by the Local Ethics Committee of the Medical University of Bialystok, Poland, and written informed consent was obtained from each participant (APK.002.364.2021).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics declarations"}}],"article-number":"40849"}}